Atea Pharmaceuticals is based in Boston, MA. It has raised $500M in total funding. Latest round: IPO.
Atea Pharmaceuticals funding overview
Atea Pharmaceuticals is based in Boston, MA. Atea Pharmaceuticals has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO. Investors on record include Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group and 1 others. 7 distinct backers are named across the disclosed rounds.
Atea Pharmaceuticals at a glance
Total raised
$500M
Latest round
IPO
Headquarters
Boston, MA
Notable investors
Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group, Fidelity Management & Research Company
Frequently asked about Atea Pharmaceuticals funding
How much has Atea Pharmaceuticals raised?
Atea Pharmaceuticals has raised $500M in total disclosed funding across the rounds on record.
Who has invested in Atea Pharmaceuticals?
Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group are named among the investors backing Atea Pharmaceuticals.
What was the latest Atea Pharmaceuticals funding round?
The most recent disclosed round is an IPO.
Where is Atea Pharmaceuticals based?
Atea Pharmaceuticals is based in Boston, MA.
Round data for Atea Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
